Skip to main content
Figure 3 | Journal of Translational Medicine

Figure 3

From: MicroRNA-134 as a potential plasma biomarker for the diagnosis of acute pulmonary embolism

Figure 3

Relative plasma microRNA-134 levels in low-risk acute pulmonary embolism and high-intermediate-risk acute pulmonary embolism. APE, acute pulmonary embolism; Low APE, low-risk acute pulmonary embolism; HI-APE, high-intermediate-risk acute pulmonary embolism; miR-134, microRNA-134. The data are normalized by the expression levels of microRNA-16. *, P < 0.05, compared to high-intermediate-risk acute pulmonary embolism patients.

Back to article page